Log in or Sign up for Free to view tailored content for your specialty!
Respiratory Infections News
More convenient COVID-19 vaccination options could help uptake, survey finds
More convenient COVID-19 vaccination options could increase uptake among children and adults, according to survey findings published in JAMA Network Open.
‘Unusual’ exposures identified among HCP in M. tuberculosis outbreak
A tuberculosis outbreak, which was linked to a viable bone allograft product contaminated with Mycobacterium tuberculosis, resulted in ”unusual” exposures for health care personnel, according to the outbreak investigation.
Log in or Sign up for Free to view tailored content for your specialty!
Hybrid COVID-19 immunity offers higher protection than previous infection alone
People who are vaccinated and have previously been infected with COVID-19 had a 97% reduced chance of severe COVID-19 infection year after their last vaccination or infection, researchers determined.
White House plans to end COVID-19 health emergencies in May
The Biden Administration plans to end the COVID-19 emergency declarations on May 11, the White House announced Monday.
COVID-19 a leading cause of death among American youths
COVID-19 has become a leading cause of death among children and teens in the United States, according to study findings published in JAMA Network Open.
Most COVID-19 outbreaks in nursing homes in second half of 2021 linked to delta variant
COVID-19 outbreaks in nursing homes throughout the last 6 months of 2021 were largely caused by the delta variant, although researchers found that COVID-19 vaccination offered significant protection against infection and death to residents.
FDA committee endorses plan to simplify COVID-19 vaccines
An FDA advisory committee voted unanimously Thursday in favor of a plan to streamline and simplify COVID-19 vaccine compositions in the United States by replacing initial, primary doses with the bivalent vaccines currently used as boosters.
CDC publishes first estimates of bivalent boosters’ effectiveness against XBB.1.5
The CDC for the first time has estimated how effective the bivalent COVID-19 vaccines have been against the newest dominant omicron subvariant of SARS-CoV-2.
Real-world impact of nirmatrelvir plus ritonavir on SARS-CoV-2 infection
As the COVID-19 pandemic heads into its 4th year, it is a good time to reflect on strides made for those with mild-to-moderate disease not requiring hospitalization.
Hooked on ID with Anthony S. Fauci, MD
What drew me to infectious diseases was the potentially enormous impact it has — not only on individuals but on societies.